Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients

Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients

Fibroblast growth factors (FGFs) are involved in numerous metabolic processes. The endocrine subfamily of FGFs, consisting of FGF19, FGF21, and FGF23, might have beneficial effects in the treatment of diabetes mellitus (DM) and/or obesity. The analog with the greatest potential, FGF21, lowers blood...

Full description

Bibliographic Details
Main Authors: Ronald J. Corbee, Dion L. van Everdingen, Hans S. Kooistra, Louis C. Penning
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Veterinary Science
Subjects:
glucose
metabolism
obesity
insulin
FGF
endocrine
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.1086987/full

Similar Items

Similar Items